Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update

Synopsis

• In 2022, there will be more than 210,000 diagnosed prevalent cases of SCLC across 16 pharmaceutical markets
• There are three leading marketed drugs for the treatment of SCLC, AstraZeneca is a key player in the disease space
• The SCLC pipeline consists of 149 pharmaceuticals spanning all stages of development, with approximately 17% of drugs in late-stage development
• Commercial sponsors dominate clinical trial development in SCLC, with the US emerging as the key countries for conducting trials in SCLC
• Deals involving partnership of SCLC assets are the most common type of deals globally
• A total of six commercial launches are expected in the next 18 months across the US, EU and Japan

Scope

• Disease Landscape
• Disease Overview
• Epidemiology Overview
• Treatment Overview
• Marketed Products Assessment
• Breakdown by Mechanism of Action, Molecule Type and Route of Administration
• Product Profiles with Sales Forecast
• Pipeline Assessment
• Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
• Late-to-mid-stage Pipeline Drugs
• Phase Transition Success Rate and Likelihood of Approval
• Clinical Trials Assessment
• Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
• Enrolment Analytics, Site Analytics, Feasibility Analysis
• Deals Landscape
• Mergers, Acquisitions, and Strategic Alliances by Region
• Overview of Recent Deals
• Commercial Assessment
• Key Market Players
• Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline
• Develop business strategies by understanding the trends shaping and driving the Small Cell Lung Cancer market
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Small Cell Lung Cancer market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships